Skip to main content
Top
Published in: European Archives of Psychiatry and Clinical Neuroscience 2/2014

01-03-2014 | Editorial

The new risk variant CACNA1C and brain circuits in schizophrenia

Authors: Andrea Schmitt, Peter Falkai

Published in: European Archives of Psychiatry and Clinical Neuroscience | Issue 2/2014

Login to get access

Excerpt

In recent genome-wide association studies of severe psychiatric disorders, several risk genes have been detected, but their neurobiological function is widely unknown. A polymorphism in the gene encoding the alpha-1C subunit of the L-type voltage-gated calcium channel (CACNA1C) has been associated with schizophrenia and bipolar disorder and may have impact on structure and function of the amygdala. Wolf et al. [1] investigated the influence of the SNP rs1006737 in CACNA1C on gray matter volumes of the amygdala in patients with schizophrenia, bipolar disorder and obsessive compulsive disorder (OCD). The risk genotype had significant effect on the relative amygdala volume in patients with schizophrenia, while this group and bipolar patients had a smaller left amygdala compared to controls. This supports the hypothesis of disturbed calcium metabolism as a neurobiological background of affective symptoms in schizophrenia. However, CACNA1C is also known to be involved in learning and memory. In a functional MRI study of two independent samples of healthy probands, Krug et al. [2] investigated the impact of rs1006737 on episodic memory encoding and retrieval in the right hippocampus. In both samples, they replicated that in the retrieval condition, carriers of the minor allele (A) had lower activations than G/G allele carriers, thus strengthening the hypothesis that this risk genotype is associated with dysfunction of hippocampus-related memory processes. …
Literature
1.
go back to reference Wolf C, Mohr H, Schneider-Axmann T, Reif A, Wobrock T, Scherk H, Gruber O (2013) CACNA1C genotype explains interindividual differences in amygdala volume among patients with schizophrenia. Eur Arch Psychiatry Clin Neurosci. doi:10.1007/s00406-013-0427-y Wolf C, Mohr H, Schneider-Axmann T, Reif A, Wobrock T, Scherk H, Gruber O (2013) CACNA1C genotype explains interindividual differences in amygdala volume among patients with schizophrenia. Eur Arch Psychiatry Clin Neurosci. doi:10.​1007/​s00406-013-0427-y
2.
go back to reference Krug A, Witt SH, Backes H, Dietsche B, Nieratschker V, Shah NJ, Kircher T (2013) A genome-wide supported variant in CACNA1C influences hippocampal activation during episodic memory encoding and retrieval. Eur Arch Psychiatry Clin Neurosci. doi:10.1007/s00406-013-0428-x Krug A, Witt SH, Backes H, Dietsche B, Nieratschker V, Shah NJ, Kircher T (2013) A genome-wide supported variant in CACNA1C influences hippocampal activation during episodic memory encoding and retrieval. Eur Arch Psychiatry Clin Neurosci. doi:10.​1007/​s00406-013-0428-x
3.
go back to reference Klingner CM, Kerstin L, Maren D, Stefan S, Otto WW, Heinrich S, Igor N (2013) Thalamocortical connectivity during resting state in schizophrenia. Eur Arch Psychiatry Clin Neurosci. doi:10.1007/s00406-013-0417-0 Klingner CM, Kerstin L, Maren D, Stefan S, Otto WW, Heinrich S, Igor N (2013) Thalamocortical connectivity during resting state in schizophrenia. Eur Arch Psychiatry Clin Neurosci. doi:10.​1007/​s00406-013-0417-0
4.
go back to reference Xu H, Hong-Ju Y, Xin-Min L (2013) Differential effects of antipsychotics on the development of rat oligodendrocyte precursor cells exposed to cuprizone. Eur Arch Psychiatry Clin Neurosci. doi:10.1007/s00406-013-0414-3 Xu H, Hong-Ju Y, Xin-Min L (2013) Differential effects of antipsychotics on the development of rat oligodendrocyte precursor cells exposed to cuprizone. Eur Arch Psychiatry Clin Neurosci. doi:10.​1007/​s00406-013-0414-3
5.
go back to reference Grohmann RR, Engel R, Möller H-J, Rüther E, van der Velden JW, Stübner S (2013) Flupentixol use and adverse reactions in comparison with other common first-and second-generation antipsychotics: data from the AMSP study. Eur Arch Psychiatry Clin Neurosci. doi:10.1007/s00406-013-0419-y Grohmann RR, Engel R, Möller H-J, Rüther E, van der Velden JW, Stübner S (2013) Flupentixol use and adverse reactions in comparison with other common first-and second-generation antipsychotics: data from the AMSP study. Eur Arch Psychiatry Clin Neurosci. doi:10.​1007/​s00406-013-0419-y
6.
go back to reference Sass K, Stefan H, Olga S, Benjamin S, Frank S, Ute H, T Kircher (2013) Neural correlates of semantic associations in patients with schizophrenia. Eur Arch Psychiatry Clin Neurosci. doi:10.1007/s00406-013-0425-0 Sass K, Stefan H, Olga S, Benjamin S, Frank S, Ute H, T Kircher (2013) Neural correlates of semantic associations in patients with schizophrenia. Eur Arch Psychiatry Clin Neurosci. doi:10.​1007/​s00406-013-0425-0
7.
go back to reference Raballo A, Anna M, Angelo C, Davide S, Marco BLR, Andrea A, Maria TC, Antonio P, Kurt M, Heinz H (2013) Shades of vulnerability: latent structures of clinical caseness in prodromal and early phases of schizophrenia. Eur Arch Psychiatry Clin Neurosci. doi:10.1007/s00406-013-0421-4 Raballo A, Anna M, Angelo C, Davide S, Marco BLR, Andrea A, Maria TC, Antonio P, Kurt M, Heinz H (2013) Shades of vulnerability: latent structures of clinical caseness in prodromal and early phases of schizophrenia. Eur Arch Psychiatry Clin Neurosci. doi:10.​1007/​s00406-013-0421-4
8.
go back to reference Llorca P-M, Christophe L, Olivier B, Ingrid de C, Ludovic S, Hervé C, Jean-Alexandre L, Franck JB (2013) A composite scale applied to evaluate anxiety in schizophrenic patients (SAES). Eur Arch Psychiatry Clin Neurosci. doi:10.1007/s00406-013-0416-1 Llorca P-M, Christophe L, Olivier B, Ingrid de C, Ludovic S, Hervé C, Jean-Alexandre L, Franck JB (2013) A composite scale applied to evaluate anxiety in schizophrenic patients (SAES). Eur Arch Psychiatry Clin Neurosci. doi:10.​1007/​s00406-013-0416-1
9.
go back to reference Fond G, Alexandra M, Ryad T, Nora H, Alexandre M, Marion L, Jean-Francois D (2013) Comparative analysis of anti-toxoplasmic activity of antipsychotic drugs and valproate. Eur Arch Psychiatry Clin Neurosci. doi:10.1007/s00406-013-0413-4 Fond G, Alexandra M, Ryad T, Nora H, Alexandre M, Marion L, Jean-Francois D (2013) Comparative analysis of anti-toxoplasmic activity of antipsychotic drugs and valproate. Eur Arch Psychiatry Clin Neurosci. doi:10.​1007/​s00406-013-0413-4
Metadata
Title
The new risk variant CACNA1C and brain circuits in schizophrenia
Authors
Andrea Schmitt
Peter Falkai
Publication date
01-03-2014
Publisher
Springer Berlin Heidelberg
Published in
European Archives of Psychiatry and Clinical Neuroscience / Issue 2/2014
Print ISSN: 0940-1334
Electronic ISSN: 1433-8491
DOI
https://doi.org/10.1007/s00406-014-0487-7

Other articles of this Issue 2/2014

European Archives of Psychiatry and Clinical Neuroscience 2/2014 Go to the issue